FDA’s top drug regulator sued by drug company, resigns amid conduct probe

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

FDA’s top drug regulator placed on leave, citing 'toxic' work environment

Dr. George Tidmarsh was placed on administrative leave for an allegation he has denied, claiming the move is in retaliation ...
WATE Knoxville on MSN

Venezuelan president responds to recent strikes on alleged drug-running boats

News anchor Lori Tuckers discusses the latest in the ongoing tensions between the United States and Venezuela as the Trump ...

6 dead, 25 hospitalized in nationwide listeria outbreak linked to precooked pasta meals

Six people have died and 25 people have been hospitalized due to a listeria outbreak linked to recalled precooked pasta meals ...

FDA restricts children’s health products over safety concerns

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

Trump Says His 'Armed Conflict' With Drug Traffickers Does Not Involve 'Hostilities'

The government is tying itself in knots to cast murder as self-defense and avoid legal limits on the president's use of the ...

Popular cholesterol prescription recalled nationwide

The most popularly prescribed drug in the U.S. has been recalled by the Federal Drug Administration. Over 141,000 bottles of Atorvastatin Calcium Tablets, distributed by Ascend Laboratories, LLC in ...

FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns about his personal conduct,” ...

First clinical trial of pig kidney transplants gets underway

WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives. United Therapeutics, a producer of gene-edited pig kidneys, ...
Health Affairs

District Court: Restrictions On Mifepristone Illegal But Will Remain In Effect Pending FDA Reconsideration

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...

Kimberly-Clark’s $50 Billion Leap Into Health and Beauty Tests Investor Faith

NEW YORK (Reuters) -Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's ...
Le Lézard

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...